Showing results (1651-1660 of 4,056) with videos related to
Sort By:
Pageof 406
Translational Cancer Research|October 29, 2025
Combination of Danggui Buxue Tang and concurrent chemoradiotherapy improves treatment outcomes by strengthening B cell immunity in patients with nasopharyngeal carcinoma-a double-blind, randomized trialHe-Yuan Hsieh, Shih-Neng Yang, Ming-Yu Lien, et al.Translational Cancer Research|October 29, 2025
Establishment of a prognostic model and immune profiling based on phagocytic regulatory genes in hepatocellular carcinomaXiaodong Meng, Qiufang Wang, Yuan Tian, et al.Translational Cancer Research|October 29, 2025
KCNJ11 as a prognostic and therapeutic target in colon adenocarcinomaJie Chen, Fuyi XieTranslational Cancer Research|October 29, 2025
Development of a mitochondrial permeability transition-driven necrosis-linked lncRNA signature for forecasting prognosis and treatment of lung adenocarcinomaWeibin Luo, Dongfang Li, Da YaoTranslational Cancer Research|October 29, 2025
Clinical features as prognostic markers in patients with solid tumors treated with programmed cell death protein 1/programmed cell death-ligand 1 inhibitors: a retrospective cohort studyYanli Liu, Zhe Meng, Lei Hong, et al.Translational Cancer Research|October 29, 2025
Multi-gene expression assays in breast cancer: a literature reviewTsung-Yen Hsieh, Chi-Cheng Huang, Ling-Ming TsengTranslational Cancer Research|October 29, 2025
Factors affecting chemotherapy-induced peripheral neuropathy in patients with breast cancer: a cross-sectional study in ChinaQianqian Zhang, Weimin Liu, Min Wu, et al.Translational Cancer Research|October 29, 2025
Identification of basement membrane-based prognostic signature and potential therapeutic drugs in hepatocellular carcinomaGuofeng Yu, Yanxi Wu, Wei Xu, et al.Translational Cancer Research|October 29, 2025
The development and validation of a novel programmed cell death-related signature based on machine learning analysis of 15 programmed cell death patterns for predicting prognosis and therapeutic response in high-grade serous ovarian carcinomaZhidong Zhang, Wenwen Zhang, Ailin Yao, et al.Translational Cancer Research|October 29, 2025
Recent advances in development of CDK7 inhibitors and their clinical trials: a narrative reviewLingzhi Zhang, Shiqin Yang, Zhe Guan, et al.Pageof 406